ACOTEC-B(06669) has received approval from the China Food and Drug Administration for the registration of the Vericor-S2 coronary microcatheter.

ACOTEC-B (06669) announced that on January 20, 2025, the group received registration approval from the China National Medical Products Administration for the coronary artery microcatheter Vericor-S2. This product is used in percutaneous coronary artery intervention surgery to guide the guidewire through the stenotic vascular lesions, providing a passage for changing guidewires and transmitting saline solution or contrast agents. The coronary artery microcatheter Vericor-S2 has excellent maneuverability, trackability, and pushability, allowing it to navigate through narrow lesions, tortuous, and small vessels without obstruction. The company will conduct marketing activities in China at an appropriate time.